India's first Covid-19 vaccine by Bharat Biotech gets DCGI nod for human clinical trials

India's first Covid-19 vaccine by Bharat Biotech gets DCGI nod for human clinical trials

Deccan Herald
PTI,

The country's 'first' indigenous Covid-19 vaccine COVAXIN, developed by city-based Bharat Biotech in collaboration with ICMR and NIV, has got the nod for human clinical trials from the Drug Controller General of India, the company said on Monday.

The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next month.

For latest updates and live news on coronavirus, click here

The collaboration with Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) was instrumental in the development of the vaccine, the company said in a release.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

11197139

Cases

6136956

Recovered

529197

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019